kaiser semaglutide criteria Population‐level impact of 2.4 mg in patients with obesity or overweight and cardiovascular disease: A modelling study based on the SELECT trial - Nanna - 2025 - Diabetes, Obesity and Metabolism Real-World Use of Oral and

doi:10.1056/nejmoa2403347 4.Shor R, Mihalache A, Noori A, et al

At the maximum maintenance dose of 2.4mg per week, that same vial drops to roughly 4 doses

While tirzepatide can produce more pronounced weight loss, higher doses may also increase the likelihood of gastrointestinal side effects

Longer-term studies show even greater weight reduction over several months

Genetics : Factors like body mass and build can affect how the drug is distributed throughout the body

Syusyuka VG, Sergienko MY, Makurina GI, Yershova OA, Chornenka AS (2021) Characteristics of phenotypes (clinical variants) of polycystic ovary syndrome in women of reproductive age